Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML

被引：0
作者：
H J M de Jonge
C M Woolthuis
A Z Vos
A Mulder
E van den Berg
P M Kluin
K van der Weide
E S J M de Bont
G Huls
E Vellenga
J J Schuringa
机构：
[1] University Medical Center Groningen,Department of Experimental Hematology and Department of Pediatrics, Division of Pediatric Oncology/Hematology
[2] University of Groningen,Department of Experimental Hematology
[3] University Medical Center Groningen,Department of Clinical Chemistry
[4] University of Groningen,Department of Genetics
[5] University Medical Center Groningen,Department of Pathology and Medical Biology
[6] University of Groningen,Department of Pediatrics, Division of Pediatric Oncology/Hematology
[7] University Medical Center Groningen,undefined
[8] University of Groningen,undefined
[9] University Medical Center Groningen,undefined
[10] University of Groningen,undefined
[11] University Medical Center Groningen,undefined
[12] University of Groningen,undefined
来源：
Leukemia | 2011年 / 25卷
关键词：
Acute myeloid leukemia; gene expression profiling; leukemic stem cells; prognostic factors; CD34; cells; transcriptome analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In order to identify acute myeloid leukemia (AML) CD34+-specific gene expression profiles, mononuclear cells from AML patients (n=46) were sorted into CD34+ and CD34− subfractions, and genome-wide expression analysis was performed using Illumina BeadChip Arrays. AML CD34+ and CD34− gene expression was compared with a large group of normal CD34+ bone marrow (BM) cells (n=31). Unsupervised hierarchical clustering analysis showed that CD34+ AML samples belonged to a distinct cluster compared with normal BM and that in 61% of the cases the AML CD34+ transcriptome did not cluster together with the paired CD34− transcriptome. The top 50 of AML CD34+-specific genes was selected by comparing the AML CD34+ transcriptome with the AML CD34− and CD34+ normal BM transcriptomes. Interestingly, for three of these genes, that is, ankyrin repeat domain 28 (ANKRD28), guanine nucleotide binding protein, alpha 15 (GNA15) and UDP-glucose pyrophosphorylase 2 (UGP2), a high transcript level was associated with a significant poorer overall survival (OS) in two independent cohorts (n=163 and n=218) of normal karyotype AML. Importantly, the prognostic value of the continuous transcript levels of ANKRD28 (OS hazard ratio (HR): 1.32, P=0.008), GNA15 (OS HR: 1.22, P=0.033) and UGP2 (OS HR: 1.86, P=0.009) was shown to be independent from the well-known risk factors FLT3-ITD, NPM1c+ and CEBPA mutation status.
引用
收藏
页码：1825 / 1833
页数：8
相关论文
共 233 条
[11]  
Edwards CG(2009)Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome Blood 113 3088-3091
[12]  
Arthur DC(1997)Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 730-737
[13]  
Falini B(1994)A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 645-648
[14]  
Mecucci C(2004)Concepts of human leukemic development Oncogene 23 7164-7177
[15]  
Tiacci E(2005)Cancer stem cells: lessons from leukemia Trends Cell Biol 15 494-501
[16]  
Alcalay M(2009) assays to study self-renewal and long-term expansion of genetically modified primary human acute myeloid leukemia stem cells Methods Mol Biol 538 287-300
[17]  
Rosati R(2007)Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells Exp Hematol 35 1538-1549
[18]  
Pasqualucci L(1997)Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability Blood 89 3104-3112
[19]  
Nakao M(1998) and Blood 92 4325-4335
[20]  
Yokota S(2000)Most acute myeloid leukemia progenitor cells with long-term proliferative ability Exp Hematol 28 660-671
12345678910